---
title: Evaluating the FDA's Diversity Action Plans for Clinical Trials
publishDate: 2019-10-02 00:00:00
img: https://assets.medpagetoday.net/media/images/111xxx/111834.jpg?width=0.8
img_alt: The Food and Drug Administration headquarters
description: |
  A critical analysis reveals opportunities and challenges prior to the finalization of the FDA's DEI guidance for clinical studies.
category: Article
tags:
  - FDA
  - Clinical Trials
  - Diversity
---

Check out my <a href="https://www.medpagetoday.com/opinion/second-opinions/111834?trw=no">opinion piece on the FDA's guidance for underrepresented groups in clincial studies</a> that I wrote with Dr. Arthur Lazarus, published in MedPage Today.

> While comprehensive and well-intentioned, its implementation may pose challenges, particularly for smaller sponsors. Enhancements in clarity, support for implementation, and enforcement mechanisms could further strengthen its impact.